Select Journal or Resource JAMA & Archives Home JAMA Archives of   Dermatology   Facial Plastic Surgery   Family Medicine (1992-2000)   General Psychiatry   Internal Medicine   Neurology   Neurology and Psychiatry (1919-1959)   Ophthalmology   Otolaryngology—Head & Neck Surgery   Pediatrics & Adolescent Medicine   Surgery JAMA & Archives CME Calendar of Events JAMA Career Center For The Media JAMAevidence AMA Manual of Style Peer Review Congress JAMA-français

Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In Vol. 3 No. 11, November 1994   Archives  • Online Features Clinical Reviews  This Article  • Abstract  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal A Critical Review of the New Oral Cephalosporins Considerations and Place in Therapy Daniel P. Rodman, pharmD; Jerry T. McKnight, MD; Russell L. Anderson, MD Arch Fam Med. 1994;3(11):975-980. References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF. 1. Tomasz A. The mechanism of the irreversible antimicrobial effects of penicillins: how the betalactam antibiotics kill and lyse bacteria. Annu Rev Microbiol. 1979;33:113-137. PUBMED 2. Rodriquez WJ, Khan W, Sait T, et al. Cefixime vs cefaclor in the treatment of acute otitis media in children: a randomized, comparative study. Pediatr Infect Dis J. 1993;12:70-74. PUBMED 3. Kiani R, Johnson D, Nelson B. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Am J Med. 1988;85(suppl3A):6-13. PUBMED 4. Irvani A, Richard G, Johnson D, Bryant A. A doubleblind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of urinary tract infections in adult patients. Am J Med. 1988;85(suppl 3A):17-23. PUBMED 5. Levenstein J, Summerfield PJF, Fourie S, et al. Comparison of cefixime and cotrimoxazole in acute uncomplicated urinary tract infection: a doubleblind general practice study. S Afr Med J. 1986;70:455-460. PUBMED 6. Handsfield HH, McCormack MD, Hook EW III, et al. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. N Engl J Med. 1991;325:1337-1341. PUBMED 7. Aronovitz GH, Doyle CA, Durham SJ, et al. Cefprozil vs amoxicillin/clavulanate in the treatment of acute otitis media. Infect Med. 1992;9 (suppl C):19-32. 8. Poole JM, Rosenberg R, Aronovitz GH, et al. Cefprozil vs cefixime and cefaclor in otitis media in children. Infect Med. 1992;9(suppl E):21-32. 9. Doyle CA, Durham SJ, Hamilton HA, et al. Cefprozil vs cefaclor in the treatment of pharyngitis and tonsillitis in adults. Infect Med. 1992;9 (suppl E):66-67. 10. De la Garza CA, Nolen TM, Rogan MP. Cefprozil vs erythromycin in streptococcal tonsillopharyngitis. Infect Med. 1992;9(suppl E):8-20. PUBMED 11. Bonnet JP, Ginsberg O, Nolen TM, et al. Cefprozil vs cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on bronchitis. Infect Med. 1992;9(suppl E):48-56. 12. Barbarash RA, Solomon E, Thieneman A Jr, et al. Ceprozil vs amoxicillin/clavulanate in mild to moderate lower respiratory tract infections: a focus on bronchitis. Infect Med. 1992;9(suppl E):40-47. 13. Wachs G, Rogan MP, Cefprozil Multicenter Study Group. Cefprozil vs erythromycin for mild to moderate skin and skin structure infections. Infect Med. 1992;9(suppl E):57-65. 14. Solomon E, McCarty JM, Morman MR, et al. Comparison of cefprozil and amoxicillin/clavulanate potassium in the treatment of skin and skin structure infections in adults. Adv Ther. 1992;9:156-164. 15. Shiba K, Saito A, Shimada J, et al. Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method. Kansenshogaku Zasshi. 1988;62:973-1001. PUBMED 16. Zuck P, Riol U, lchou F. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia. J Antimicrob Chemother. 1990;26(suppl E):71-77. FREE FULL TEXT 17. Mendelman PM, Del Beccaro MA, McLinn SE, Todd WM. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media. J Pediatr. 1992;121:459-465. PUBMED 18. Dere WH, Farlow D, Therasse DG, Ruoff GE. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis. Clin Ther. 1992;14:41-53. PUBMED 19. Hyslop DL, Jacobson K, Guerra FJ. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia. Clin Ther. 1992;14:254-267. PUBMED 20. Nielsen RW. Acute bacterial maxillary sinusitis: results of US and European comparative trials. Am J Med. 1992;92(suppl 6A):70S-73S. PUBMED 21. Foshee WS. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion. J Pediatr. 1992;120:980-986. PUBMED 22. McCarty J. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adult population. Am J Med. 1992;92 (suppl 6A):74S-79S. PUBMED 23. McCarty J, Ruoff GE, Jacobson KD. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population. Am J Med. 1992;92(suppl6A):80S-85S. PUBMED 24. Irvani A. Loracarbef versus cefaclor in the treatment of urinary tract infections in women. Antimicrob Agents Chemother. 1991;35:750-752. FREE FULL TEXT 25. Hyslop DL, Bischoff W. Loracarbef (LY163892) versus cefaclor and norfloxin in the treatment of uncomplicated pyelonephritis. Am J Med. 1992;92(suppl 6A):86S-94S. PUBMED 26. Red Book. Oradell, NJ: Medical Economics Books; 1994.